JTT-654, an 11-beta hydroxysteroid dehydrogenase type 1 inhibitor, improves hypertension and diabetic kidney injury by suppressing angiotensinogen production

Autor: Heitaku, Shiro, Sasase, Tomohiko, Sotani, Tomohiro, Maki, Mimi, Kawai, Takashi, Morinaga, Hisayo, Nishiu, Jun
Zdroj: In Journal of Pharmacological Sciences April 2024 154(4):246-255
Databáze: ScienceDirect